Kadcyla Trastuzumab Emtansine 160mg Injection
Kadcyla (Trastuzumab Emtansine) 160mg Injection is an advanced targeted anti-cancer medication used primarily for the treatment of HER2-positive breast cancer. It is an antibody-drug conjugate (ADC) that combines the HER2-targeting action of trastuzumab with a powerful chemotherapy agent (emtansine or DM1).
This innovative formulation allows Kadcyla to specifically target cancer cells that overexpress the HER2 protein, delivering chemotherapy directly inside the cancer cells while minimizing damage to healthy tissues. This targeted approach improves treatment effectiveness and reduces many of the side effects associated with traditional chemotherapy.
Kadcyla is commonly prescribed for patients with:
- HER2-positive metastatic breast cancer
- Early-stage HER2-positive breast cancer with residual disease after neoadjuvant therapy
📞 Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
Composition and Content
- Active Ingredient: Trastuzumab Emtansine
- Strength: 160 mg per vial
- Form: Lyophilized powder for injection
- Class: Antibody-Drug Conjugate (ADC)
Uses of Kadcyla 160mg Injection
Kadcyla is used in the treatment of:
- HER2-positive metastatic breast cancer
- Adjuvant treatment of HER2-positive early breast cancer
- Patients previously treated with trastuzumab and taxane-based chemotherapy
How It Works
Kadcyla works in a targeted manner:
- Trastuzumab binds to HER2 receptors on cancer cells
- The drug enters the cancer cell
- Emtansine (DM1) is released inside the cell
- It destroys the cancer cell from within
Advantages of Kadcyla Injection
- Targeted cancer therapy with higher precision
- Reduced damage to healthy cells
- Improved survival rates in HER2-positive patients
- Lower systemic toxicity compared to conventional chemotherapy
- Effective in patients resistant to trastuzumab alone
Dosage and Administration
- Administered as an intravenous infusion
- Typical dose: 3.6 mg/kg every 3 weeks (as prescribed by an oncologist)
- Must be given under medical supervision
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original packaging to protect from light
- Use immediately after reconstitution
Alternate Indian Brands for Trastuzumab Emtansine
While Kadcyla is a branded product, availability of biosimilars or alternatives may vary. Some related HER2-targeted therapies include:
- Trastuzumab injections (e.g., Herclon, Canmab)
- Pertuzumab combinations (used alongside trastuzumab)
(Note: Exact biosimilar of Trastuzumab Emtansine may have limited availability in India; consult your oncologist for suitable alternatives.)
Buy Kadcyla Trastuzumab Emtansine 160mg Injection Online from GlobMedIndia – The Medicine Exporter
Looking to buy Kadcyla 160mg Injection online at the best price? GlobMedIndia – The Medicine Exporter offers genuine and high-quality anti-cancer medicines with fast, safe, and reliable international delivery.
We specialize in exporting life-saving oncology drugs including Kadcyla (Trastuzumab Emtansine) to multiple global destinations such as:
USA, UK, UAE, Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.
Why Choose GlobMedIndia?
- 100% genuine anti-cancer medicines
- Competitive pricing
- Cold-chain shipping for temperature-sensitive drugs
- Fast worldwide delivery
- Expert support and assistance
- Kadcyla 160mg Injection price
- Trastuzumab Emtansine buy online
- HER2 breast cancer targeted therapy
- Kadcyla injection supplier India
- Buy anti cancer medicines online India
- GlobMedIndia medicine exporter
- Kadcyla injection international shipping
- HER2 positive breast cancer treatment drugs
- Trastuzumab emtansine availability worldwide
Conclusion
Kadcyla Trastuzumab Emtansine 160mg Injection represents a breakthrough in targeted cancer therapy, offering improved outcomes for patients with HER2-positive breast cancer. With its precision mechanism and reduced side effects, it has become a preferred choice among oncologists globally.
For safe procurement and global delivery, GlobMedIndia ensures access to authentic oncology medicines with professional support and reliable service.
